Accredited Newsletter Series

The Multidisciplinary Cancer Care™ accredited series of newsletters are jointly sponsored by CME Consultants and Center of Excellence Media. This newsletter series is supported by an educational grant from Millennium Pharmaceuticals, Inc.

To assist us in evaluating the effectiveness of these activities and to make recommendations for future educational offerings, please take a few minutes to complete the evaluation form for each newsletter in the series. You must complete each evaluation form to receive acknowledgement for completing these activities.

Hardware/Software Requirements
MediCom Worldwide, Inc. requires Internet Explorer® version 7.0 or higher, or Firefox 3.0 or higher, a computer running Windows® XP, Windows® Vista, or Mac OS X, 512MB of RAM or greater, 1.5 GHZ or faster processor, and a screen resolution of 1024x768 or higher. Certain educational activities may require additional software to view. These activities will be marked with the information and/or links to the required software. That software may be Adobe® Flash® Player, Adobe® Acrobat®, Windows Media® Player or Microsoft®Silverlight™.

Considerations in Multiple Myeloma: Stem Cell Mobilization
Considerations in Multiple Myeloma: Stem Cell Mobilization
CME, CPE, CNE
Release Date: August 31, 2009
Expiration Date: August 31, 2010
Clinical trials addressing stem cell mobilization are discussed, including implications for nurses and pharmacists.
View Only, CE Expired
 
Considerations in Multiple Myeloma: Cytogenetic Testing
Considerations in Multiple Myeloma: Cytogenetic Testing
CME, CPE, CNE
Release Date: September 30, 2009
Expiration Date: September 30, 2010
This newsletter discusses the impact of cytogenetics on the appropriate treatment of and patient outcomes in multiple myeloma.
Program Menu
 
Recent Advances in the Treatment of Multiple Myeloma
Recent Advances in the Treatment of Multiple Myeloma
CPE
Release Date: September 30, 2009
Expiration Date: September 30, 2010
This newsletter addresses issues particularly applicable to pharmacists involved in treating myeloma patients, such as chemotherapy dosing and management of side effects.
Program Menu
 
Conference Faculty Perspectives: Compendium from ASH, the XII International Myeloma Workshop, and the Pan Pacific Lymphoma Conference
Conference Faculty Perspectives: Compendium from ASH, the XII International Myeloma Workshop, and the Pan Pacific Lymphoma Conference
CME, CPE, CNE
Release Date: November 16, 2009
Expiration Date: November 16, 2010
This newsletter relates the findings of clinical trials with novel agents as reported at a meeting of the American Society of Hematology.
Program Menu
 
Considerations in Multiple Myeloma: Sequencing Strategies
Considerations in Multiple Myeloma: Sequencing Strategies
CME, CPE, CNE
Release Date: November 16, 2009
Expiration Date: November 16, 2010
The research supporting sequencing strategies are presented in this newsletter.
Program Menu
 
Considerations in Multiple Myeloma: To Transplant or Not to Transplant…  That Is the Question!
Considerations in Multiple Myeloma: To Transplant or Not to Transplant… That Is the Question!
CME, CPE, CNE
Release Date: November 16, 2009
Expiration Date: November 16, 2010
This newsletter reports on the role of transplantation within the realm of novel therapies for multiple myeloma.
Program Menu
 
Considerations in Multiple Myeloma: Perspectives on Relevant End Points of Clinical Trials
Considerations in Multiple Myeloma: Perspectives on Relevant End Points of Clinical Trials
CME, CPE, CNE
Release Date: July 14, 2009
Expiration Date: July 14, 2010
This newsletter outlines the definitive endpoints for the evaluation of clinical trial results and uses a case study to exemplify and discuss the role of nurses in clinical trials.
View Only, CE Expired
 
Conference Faculty Perspectives: Interpreting Key Multiple Myeloma Data from the XII International Myeloma Workshop
Conference Faculty Perspectives: Interpreting Key Multiple Myeloma Data from the XII International Myeloma Workshop
CME, CPE, CNE
Release Date: June 29, 2009
Expiration Date: June 29, 2010
This newsletter reviews key points from the XII International Myeloma Workshop, including novel agents, response criteria, and the correlation between clinical response and patient outcomes.
View Only, CE Expired
 
Considerations in Multiple Myeloma: Do Complete Responses Correlate with Clinical Benefit?
Considerations in Multiple Myeloma: Do Complete Responses Correlate with Clinical Benefit?
CME, CPE, CNE
Release Date: June 10, 2009
Expiration Date: June 10, 2010
The correlation between complete response and survival in multiple myeloma patients is exemplified through the results of several clinical trials.

View Only, CE Expired
Program Menu
 
Considerations in Multiple Myeloma: Maintenance Therapy
Considerations in Multiple Myeloma: Maintenance Therapy
CME, CPE, CNE
Release Date: May 11, 2009
Expiration Date: May 11, 2010
Considerations in Multiple Myeloma: Maintenance Therapy is one in a series of newsletters featuring topics relevant to a multidisciplinary team approach to caring for patients with MM

View Only, CE Expired
Program Menu
 
Conference Faculty Perspectives: Interpreting Key Multiple Myeloma Data from ASH 2008
Conference Faculty Perspectives: Interpreting Key Multiple Myeloma Data from ASH 2008
CME, CPE, CNE
Release Date: April 30, 2009
Expiration Date: April 30, 2010
This newsletter reviews high points of the ASH 2008 conference, including trials of second-generation proteasome inhibitors and combinations of novel agents for the treatment of multiple myeloma.

View Only, CE Expired
Program Menu
 
Considerations in Multiple Myeloma: Retreatment Settings
Considerations in Multiple Myeloma: Retreatment Settings
CME, CPE, CNE
Release Date: March 31, 2009
Expiration Date: March 31, 2010
A series of four articles discuss recent clinical trial findings, diagnosis, quality of life improvements and salvage therapies in the relapsed/refractory multiple myeloma patient.

View Only, CE Expired
Program Menu
 
Considerations in Multiple Myeloma: Side Effect Management - CME, CNE, CPE
Considerations in Multiple Myeloma: Side Effect Management - CME, CNE, CPE
Release Date: November 24, 2008
Expiration Date: November 24, 2009
Considerations in Multiple Myeloma: Side Effect Management is one in a series of newsletters featuring topics relevant to a multidisciplinary team approach to caring for patients with MM
View Only, CE Expired
 
Considerations in Multiple Myeloma: Health Economics - CME, CNE, CPE
Considerations in Multiple Myeloma: Health Economics - CME, CNE, CPE
Release Date: October 31, 2008
Expiration Date: October 31, 2009
Considerations in Multiple Myeloma: Health Economics is one in a series of newsletters featuring topics relevant to a multidisciplinary team approach to caring for patients with MM
View Only, CE Expired
 
Considerations in Multiple Myeloma: Hard-to-Treat Patients - CME, CNE, CPE
Considerations in Multiple Myeloma: Hard-to-Treat Patients - CME, CNE, CPE
Release Date: August 29, 2008
Expiration Date: August 29, 2009
Considerations in Multiple Myeloma: Hard-to-Treat Patients is one in a series of newsletters featuring topics relevant to a multidisciplinary team approach to caring for patients with MM
View Only, CE Expired
 
Considerations in Multiple Myeloma: Treatment-Naive Patients - CME, CNE, CPE
Considerations in Multiple Myeloma: Treatment-Naive Patients - CME, CNE, CPE
Release Date: July 31, 2008
Expiration Date: July 31, 2009
Considerations in Multiple Myeloma: Treatment-Naive Patients is one in a series of newsletters featuring topics relevant to a multidisciplinary team approach to caring for patients with MM
View Only, CE Expired
 
Front-Line Therapy for Multiple Myeloma
Front-Line Therapy for Multiple Myeloma
Release Date: May 25, 2008
Expiration Date: May 25, 2009
Proceeding from a Roundtable Conference Incorporating Data from ASH 2007
View Only, CE Expired
 
Considerations in Multiple Myeloma: Renal Dysfunction
Considerations in Multiple Myeloma: Renal Dysfunction
Release Date: May 07, 2008
Expiration Date: May 07, 2009
Considerations in Multiple Myeloma: Renal Dysfunction is one in a series of newsletters featuring topics relevant to a multidisciplinary team approach to caring for patients with MM
View Only, CE Expired